Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.09K Sell
29
-587
-95% -$71.1K ﹤0.01% 1419
2026
Q1
$101K Buy
616
+573
+1,333% +$88.1K 0.01% 545
2025
Q4
$7.48K Buy
43
+17
+65% +$3.1K ﹤0.01% 1206
2025
Q3
$3.74K Buy
+26
New +$3.19K ﹤0.01% 1189

Other funds holding INSM

Quent Capital's INSM Position: Q2 2026 in Review

Quent Capital reduced its Insmed (INSM) stake by 95% in Q2 2026, selling an estimated $71.1K and leaving 29 shares worth $3.09K. The position accounts for ﹤0.01% of the portfolio, ranked #1419.

Quent Capital first reported a position in INSM in Q3 2025 and has held it in 4 quarters since. The position peaked at $101K in Q1 2026. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Quent Capital held 29 shares of Insmed worth $3.09K as of Q2 2026.
  • Quent Capital sold 587 Insmed shares in Q2 2026, an estimated $71.1K.
  • Insmed made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #1419 holding.
  • Quent Capital first reported a position in Insmed in Q3 2025 and has held it in 4 quarters since.
  • Quent Capital's Insmed position peaked at $101K in Q1 2026.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.